Treatment of refractory delayed onset heparin-induced thrombocytopenia after thoracic endovascular aortic repair with intravenous immunoglobulin (IVIG)

被引:19
作者
Doucette, Kimberley [1 ]
DeStefano, Christin B. [2 ]
Jain, Natasha A. [1 ]
Cruz, Allan L. [2 ]
Malkovska, Vera [2 ]
Fitzpatrick, Kelly [2 ]
机构
[1] Medstar Washington Hosp Ctr, Dept Internal Med, Washington, DC 20010 USA
[2] Medstar Washington Hosp Ctr, Dept Hematol Oncol, Washington, DC USA
关键词
heparin; immunoglobulins; intravenous; thrombocytopenia; thrombosis;
D O I
10.1002/rth2.12009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Delayed onset heparin induced thrombocytopenia (HIT), is characterized by a late nadir due to persistent platelet-activating IgG antibodies. It typically begins or worsens 5 or more days after heparin is discontinued with complications such as thrombosis up to 3 weeks after exposure to heparin.(1-3) In 50% of cases, the platelet count can decrease to very low numbers (<20 000/mu L), which is not usual for typical HIT. Here we report 2 cases of post-operative delayed onset HIT manifesting as severe thrombocytopenia that persisted despite cessation of heparin and initiation of argatroban. Key Clinical Question: Is intravenous immunoglulin beneficial in severe refractory delayed-onset HIT?
引用
收藏
页码:134 / 137
页数:4
相关论文
共 19 条
[1]   CORRECTION OF SEVERE HEPARIN-ASSOCIATED THROMBOCYTOPENIA WITH INTRAVENOUS IMMUNOGLOBULIN [J].
FRAME, JN ;
MULVEY, KP ;
PHARES, JC ;
ANDERSON, MJ .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (11) :946-947
[2]   HEPARIN-INDUCED THROMBOCYTOPENIA - RESPONSE TO INTRAVENOUS IMMUNOGLOBULIN INVIVO AND INVITRO [J].
GRAU, E ;
LINARES, M ;
OLASO, MA ;
RUVIRA, J ;
SANCHIS, J .
AMERICAN JOURNAL OF HEMATOLOGY, 1992, 39 (04) :312-313
[3]  
GREINACHER A, 1994, THROMB HAEMOSTASIS, V71, P641
[4]   Heparin-induced thrombocytopenia [J].
Greinacher, A. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 :9-12
[5]   Progressive thrombocytopenia after cardiac surgery in a 67-year-old man [J].
Kopolovic, Ilana ;
Warkentin, Theodore E. .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2014, 186 (12) :929-933
[6]   Rapid and durable response to intravenous immunoglobulin in delayed heparin-induced thrombocytopenia: a case report [J].
Lei, Brandon Z. ;
Shatzel, Joseph J. ;
Sendowski, Merav .
TRANSFUSION, 2017, 57 (04) :919-923
[7]   The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia [J].
Lubenow, Norbert ;
Hinz, Peter ;
Thomaschewski, Simone ;
Lietz, Theresia ;
Vogler, Michael ;
Ladwig, Andrea ;
Juenger, Michael ;
Nauck, Matthias ;
Schellong, Sebastian ;
Wander, Kathrin ;
Engel, Georg ;
Ekkernkamp, Axel ;
Greinacher, Andreas .
BLOOD, 2010, 115 (09) :1797-1803
[8]   IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia [J].
Padmanabhan, Anand ;
Jones, Curtis G. ;
Pechauer, Shannon M. ;
Curtis, Brian R. ;
Bougie, Daniel W. ;
Irani, Mehraboon S. ;
Bryant, Barbara J. ;
Alperin, Jack B. ;
Deloughery, Thomas G. ;
Mulvey, Kevin P. ;
Dhakal, Binod ;
Wen, Renren ;
Wang, Demin ;
Aster, Richard H. .
CHEST, 2017, 152 (03) :478-485
[9]   Antibodies to platelet factor 4 - Heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin - Clinical implications for heparin-induced thrombocytopenia [J].
Pouplard, C ;
May, MA ;
Iochmann, S ;
Amiral, J ;
Vissac, AM ;
Marchand, M ;
Gruel, Y .
CIRCULATION, 1999, 99 (19) :2530-2536
[10]   Delayed-onset heparin-induced thrombocytopenia [J].
Rice, L ;
Attisha, WK ;
Drexler, A ;
Francis, JL .
ANNALS OF INTERNAL MEDICINE, 2002, 136 (03) :210-215